Max Robotics — Global Service Robot Directory + US Certification

About

Rui Maio is a clinical researcher specializing in prostate cancer diagnostics and surgical outcomes, with a particular focus on the application of magnetic resonance imaging to improve preoperative risk stratification. His work centers on developing predictive models that integrate MRI-derived semantic features with histological and clinical variables to better characterize prostate cancer behavior prior to intervention. Maio's most significant contribution to the field is his pioneering work on early biomarkers for extracapsular extension (ECE), published in 2022 and accumulating 14 citations. This prospective 3T MRI study established a robust framework for detecting pathology-confirmed extracapsular extension before surgery — a critical factor in surgical planning and patient counseling. Building on this foundation, his subsequent 2023 research examined how these same predictive variables influence biochemical recurrence-free survival following robotic-assisted radical prostatectomy, bridging imaging findings to long-term oncological outcomes. With a growing citation record across a focused body of work, Maio represents an emerging voice in urological oncology research. His contributions are particularly valuable for clinicians seeking to refine patient selection and optimize outcomes in prostate cancer surgery, making his work highly relevant for researchers and trainees in oncological urology and medical imaging.